Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |